ALBT
NASDAQAvalon GloboCare Corp.
SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)
News25/Ratings0
Price$0.38-0.01 (-2.05%)
01:30 PM03:15 PM
News · 26 weeks52-75%
2025-12-072026-05-31
Mix2290d
- SEC Filings17(77%)
- Other5(23%)
Latest news
25 items- SECSEC Form SCHEDULE 13G filed by Avalon GloboCare Corp.SCHEDULE 13G - Avalon GloboCare Corp. (0001630212) (Subject)
- SECSEC Form 10-Q filed by Avalon GloboCare Corp.10-Q - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAmendment: Avalon GloboCare Corp. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- PRAvalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform DevelopmentFREEHOLD, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology-innovation company with a strategic focus on developing innovative products and services that serve growing consumer health and technology markets, today announced that its subsidiary, Avalon Quantum AI LLC, is collaborating with Amazon Web Services ("AWS") to support Phase 2 development of its Catch-Up agentic AI video platform. Caylent, Inc., an AWS Premier Tier Consulting Partner and a member of the AWS Generative AI Innovation Center's Partner Innovation Alliance, has been appointed to lead the development. Phase 2 of the Catch-Up platform is expected to tr
- SECSEC Form EFFECT filed by Avalon GloboCare Corp.EFFECT - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form 424B3 filed by Avalon GloboCare Corp.424B3 - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form DEFA14A filed by Avalon GloboCare Corp.DEFA14A - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form DEF 14A filed by Avalon GloboCare Corp.DEF 14A - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form S-1 filed by Avalon GloboCare Corp.S-1 - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form RW filed by Avalon GloboCare Corp.RW - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form PRE 14A filed by Avalon GloboCare Corp.PRE 14A - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Shareholder Director Nominations8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- PRAvalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video PlatformFREEHOLD, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology-innovation company with a strategic focus on developing innovative products and services that serve growing consumer health and technology markets, today announced that its subsidiary, Avalon Quantum AI LLC, has selected Caylent, Inc., a cloud-native services company and an Amazon Web Services (AWS) Premier Tier Consulting Partner, to support the development of this AWS-based initiative. This phase 2 development is expected to transition the Catch-Up software-as-a-service (SaaS) platform from a manually configured AI video production system into a fully autonomo
- SECSEC Form 10-K filed by Avalon GloboCare Corp.10-K - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAmendment: Avalon GloboCare Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K/A - Avalon GloboCare Corp. (0001630212) (Filer)
- SECSEC Form D filed by Avalon GloboCare Corp.D - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- PRPowell Max Limited Successfully Repositions for Its Next Phase of GrowthHong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (NASDAQ:PMAX) ("Powell Max" or the "Company"), a financial communications services provider, is pleased to provide the following corporate update regarding its successful repositioning. Key Highlights: Raised $17 million in capital from new investorsAppointed new Chairman and Chief Executive Officer Geordan PursgloveReconstituted the Board of DirectorsRegained compliance with Nasdaq listing requirements Powell Max Chairman and Chief Executive Officer Geordan Pursglove commented, "My first month at Powell Max has been extremely productive. We successfully completed a corporate restructuring in a short timeframe, raised
- SECSEC Form DEF 14A filed by Avalon GloboCare Corp.DEF 14A - Avalon GloboCare Corp. (0001630212) (Filer)
- SECAvalon GloboCare Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Avalon GloboCare Corp. (0001630212) (Filer)
- PRAvalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq RulesFREEHOLD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 6,372,550 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 warrants to purchase up to an aggregate of 6,372,550 shares of common stock and Series A-2 warrants to purchase up to an aggregate of 6,372,550 shares of common stock, at a purchase price of $0.51 per share (or pre-
ALBT FAQ
4 questionsWhere does ALBT stock trade?
Avalon GloboCare Corp. (ALBT) is listed on NASDAQ.What sector and industry is ALBT in?
Avalon GloboCare Corp. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.What companies are similar to ALBT?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare ALBT side-by-side with any of them on Quantisnow.How can I track ALBT on Quantisnow?
Quantisnow aggregates Avalon GloboCare Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ALBT to receive live email and push alerts on every new disclosure.